about
Pitavastatin in cardiometabolic disease: therapeutic profileFunctionally defective high-density lipoprotein and paraoxonase: a couple for endothelial dysfunction in atherosclerosisEvacetrapib is a novel, potent, and selective inhibitor of cholesteryl ester transfer protein that elevates HDL cholesterol without inducing aldosterone or increasing blood pressureObesity genotype score and cardiovascular risk in women with type 2 diabetes mellitusHDL in sepsis - risk factor and therapeutic approachApolipoprotein J: A New Predictor and Therapeutic Target in Cardiovascular Disease?Endothelial Dysfunction: Clinical Implications in Cardiovascular Disease and Therapeutic ApproachesTrypanosoma cruzi infection and host lipid metabolismSynthetic high-density lipoprotein-like nanoparticles as cancer therapyProtein C anticoagulant and cytoprotective pathwaysCardioprotective functions of HDLsThe prothrombotic tendency in metabolic syndrome: focus on the potential mechanisms involved in impaired haemostasis and fibrinolytic balanceSphingosine-1-phosphate as a mediator of high-density lipoprotein effects in cardiovascular protectionMultiple genetic variants along candidate pathways influence plasma high-density lipoprotein cholesterol concentrationsAnacetrapib, a Novel CETP Inhibitor: Pursuing a New Approach to Cardiovascular Risk ReductionLoss of PDZK1 causes coronary artery occlusion and myocardial infarction in Paigen diet-fed apolipoprotein E deficient mice.Tangier disease: epidemiology, pathophysiology, and management.Inflammation induces fibrinogen nitration in experimental human endotoxemiaLipids and carotid plaque in the Northern Manhattan Study (NOMAS)High-density lipoprotein particles and markers of inflammation and thrombotic activity in patients with untreated HIV infection.Loss of sex difference in high-density lipoprotein cholesterol in diabetic women during acute stress.Dalcetrapib: a review of Phase II data.Involvement of 4E-BP1 in the protection induced by HDLs on pancreatic beta-cells.Regression of coronary atherosclerosis with infusions of the high-density lipoprotein mimetic CER-001 in patients with more extensive plaque burdenCurrent status and future directions in lipid management: emphasizing low-density lipoproteins, high-density lipoproteins, and triglycerides as targets for therapy.Serum lipids, apolipoproteins, and mortality among coronary artery disease patientsRole of the adaptor protein PDZK1 in controlling the HDL receptor SR-BIThrombin induces endothelial arginase through AP-1 activation.High-density lipoproteins for the systemic delivery of short interfering RNA.Exogenous expression of human apoA-I enhances cardiac differentiation of pluripotent stem cells.The Combination Therapy of Fenofibrate and Ezetimibe Improved Lipid Profile and Vascular Function Compared with Statins in Patients with Type 2 Diabetes.A review on the traditional Chinese medicinal herbs and formulae with hypolipidemic effect.HDL inhibits the effects of oxidized phospholipids on endothelial cell gene expression via multiple mechanismsRelationship between serum lipid values and atherosclerotic burden in the proximal thoracic aorta.Lymphatic lipid transport: sewer or subway?Regulation of high-density lipoprotein on hematopoietic stem/progenitor cells in atherosclerosis requires scavenger receptor type BI expression.Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for managementHDL-replacement therapy: mechanism of action, types of agents and potential clinical indications.Apolipoprotein A-I attenuates palmitate-mediated NF-κB activation by reducing Toll-like receptor-4 recruitment into lipid raftsCholesteryl ester transfer protein inhibition as a strategy to reduce cardiovascular risk.
P2860
Q21246037-19B32154-9B22-46FF-98B8-0ECB57B3F26EQ24603711-A3B631B1-F8F3-4545-8A52-86272D053F2DQ24624286-555C6C82-AC5C-480B-B608-CE208E869D6BQ24633541-494D209C-8906-4A02-8F07-8D3B3D660DBEQ26777964-FC904716-C7FA-438D-B8A7-1268D9739B68Q26781196-FE6B679C-4072-4679-9D82-FE364201CD51Q26785504-BA4E3C23-A3A4-43C8-943B-137DC7350EA1Q26823791-15860816-CAF4-4048-9F73-586620259300Q26825009-F194A662-6364-4487-8C76-16129C1754EEQ26999113-43121D89-6FB0-4401-A1A7-CE354B94DAF7Q27000421-F99170FD-2A1D-41CF-BCAF-60D8AA89424FQ27003277-96348FC3-86DD-46D2-98FC-6E1D277F7176Q28235893-45A1EEDD-87C8-44DD-B4DF-7939CEC69645Q28288723-2E4151D5-F76A-4C7D-90E9-7B501BCBE0F3Q29999973-5FFFE7FE-A05B-400F-9A6A-6C24052EB784Q30942732-2EA593A1-38C5-46FC-8579-B121DE52DFE7Q33402921-70F919A2-2590-49D9-8C70-3F07B2963D7BQ33486847-8E3A692E-9953-453B-A956-D7A3FD21B0D8Q33520363-E053D461-62FB-43F8-A1DE-963F01A7CB66Q33556997-78DA9BEA-6FBF-4A0A-A82D-E98F4FA7C874Q33570203-D64B8DC6-8050-415C-A5BB-455BD2E8498FQ33577236-549B88AD-58F5-4228-BC65-53B14DBFF616Q33642067-D790AACB-9D06-42DA-B947-D3DF205EFAEDQ33714672-0AA0CA0F-9B90-4DE5-8EC8-3799A24890EEQ33715404-6FA68DA4-BB75-46AF-913B-5D1CFD00DDF1Q33760061-0A508644-C589-4589-882F-0222D6D860A4Q33767978-8A0B4F32-C263-47BF-B3C0-52C9033AC8B4Q33783523-85737CE8-3412-42E7-94BC-2913D7A2A619Q33786171-8A8D4451-B0EF-4414-AE0F-E623051AFD5FQ33904083-14F7086B-A3F8-4004-8AF8-E0A3F562521CQ33918771-E780868D-747A-454F-B5F6-56507490E228Q33942724-8DA01FA9-B0DB-4169-8D2E-E78ECBF0B050Q33945091-D5927B42-6657-4AC6-A54E-B278562EE120Q34009628-2D12C74C-E9F5-4656-88DA-375FFC4F5BABQ34036806-2CDA0A9D-77B1-42A7-A285-33695B501529Q34076242-AB9AA13B-FB7F-46AA-8C56-11CD43CAF9F6Q34181381-0580AA41-DD28-4F2C-8C58-FC6FE078AD49Q34181607-6E7F499B-DD79-4718-A50C-B7D4014D4426Q34221770-59CFB301-6B57-497B-8191-31E918DE2FC5Q34253290-82972120-EDC3-4960-90E4-4A655B7670F6
P2860
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Endothelial and antithrombotic actions of HDL.
@ast
Endothelial and antithrombotic actions of HDL.
@en
type
label
Endothelial and antithrombotic actions of HDL.
@ast
Endothelial and antithrombotic actions of HDL.
@en
prefLabel
Endothelial and antithrombotic actions of HDL.
@ast
Endothelial and antithrombotic actions of HDL.
@en
P2093
P1433
P1476
Endothelial and antithrombotic actions of HDL.
@en
P2093
Chieko Mineo
Hiroshi Deguchi
John H Griffin
Philip W Shaul
P304
P356
10.1161/01.RES.0000225982.01988.93
P577
2006-06-01T00:00:00Z